|本期目录/Table of Contents|

[1]杜鹏辉,周琦,张贻凤.腺苷A2a受体/Krüppel样因子5对缺血再灌注损伤大鼠心肌的影响[J].国际心血管病杂志,2023,03:155-160,189.
 DU PenghuiZHOU QiZHANG Yifeng.Effects of adenosine A2a receptor/Krüppel-like factor 5 on myocardial ischemia-reperfusion injury in rats[J].International Journal of Cardiovascular Disease,2023,03:155-160,189.
点击复制

腺苷A2a受体/Krüppel样因子5对缺血再灌注损伤大鼠心肌的影响(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2023年03期
页码:
155-160,189
栏目:
基础研究
出版日期:
2023-05-30

文章信息/Info

Title:
Effects of adenosine A2a receptor/Krüppel-like factor 5 on myocardial ischemia-reperfusion injury in rats
作者:
杜鹏辉周琦张贻凤
430070 武汉,中国地质大学医院
Author(s):
DU PenghuiZHOU QiZHANG Yifeng
Affiliated Hospital to China GeosciencesUniversity, Wuhan? 430070, China
关键词:
腺苷A2a受体Krüppel样因子5 心肌再灌注损伤
Keywords:
Adenosine A2a receptor Krüppel-like factor 5 Myocardial reperfusion injury
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2023.03.008
文献标识码:
-
摘要:
目的:探讨腺苷A2a受体/Krüppel样因子5(KLF5)对缺血再灌注损伤大鼠心肌的影响。方法:42只250~300g雄性SD大鼠随机分为4组:假手术组(Sham组,n=6)、缺血再灌注组(I/R组,n=12)、缺血再灌注+腺苷A2a受体特异性激动剂CGS21680组(I/R+CGS组,n=12)、缺血再灌注+腺苷A2a受体拮抗剂ZM241385组(I/R+ZM组,n=12)。采用结扎左冠状动脉前降支再灌注的方法制备大鼠心肌缺血再灌注损伤模型。I/R+CGS组于再灌注前5min静脉注射CGS21680后持续泵注60min,CGS+ZM组于再灌注前5min静脉注射ZM241385。于造模前,缺血5min,再灌注10min、45min及120min时分别记录各组大鼠的心率(HR)、平均动脉压(MAP)以及心率与收缩压乘积(RPP)。再灌注结束后取血液,酶联免疫吸附测定法检测血清心肌钙蛋白I(cTnI)和成纤维细胞生长因子21(FGF21)水平。再灌注结束后再次结扎左冠状动脉前降支,采用TTC染色法确定心肌梗死面积。处死大鼠,采用Westernblot法检测缺血区心肌组织中的肿瘤坏死因子-α(TNF-α)、白细胞介素(IL)-1β和KLF5的蛋白表达水平。结果:各组造模前、Sham组各时间点HR、MAP及RPP差异无统计学意义。与Sham组比较,I/R组缺血5min时HR、MAP及RPP降低;与I/R组比较,I/R+CGS组再灌注10min和45min时HR、MAP及RPP降低,I/R+ZM组再灌注10min和45min时HR、MAP及RPP升高(P均<0.05)。与Sham组比较,I/R组心肌梗死面积增大,血清cTnI水平升高,FGF21水平降低;与I/R组比较,I/R+CGS组心肌梗死面积减小,血清cTnI水平降低,FGF21水平升高,I/R+ZM组心肌梗死面积增大,血清cTnI水平升高,FGF21水平降低(P均<0.05)。与Sham组比较,I/R组心肌组织中TNF-α、IL-1β和KLF5的蛋白表达水平均明显升高;与I/R组相比,I/R+CGS组心肌组织中TNF-α、IL-1β和KLF5的蛋白表达水平均明显降低,I/R+ZM组心肌组织中TNF-α、IL-1β和KLF5的蛋白表达水平均明显升高(P均<0.05)。结论:激活腺苷A2a受体可抑制缺血心肌细胞中KLF5表达,降低心肌梗死再灌注损伤程度,缓解心肌细胞缺氧状态,促进心肌细胞损伤后修复,对缺血再灌注损伤大鼠心肌起保护作用。
Abstract:
Objective: To assess the effects of adenosine A2a receptor/Krüppel-like factor 5 on myocardial ischemia-reperfusion (I/R) injury in rats. Methods: Forty-two male 250~300 g SD rats were randomly divided into 4 groups: sham operation group (Sham group, n=6), I/R group (n=12), I/R+adenosine A2a receptor agonist CGS21680 group (I/R+CGS group, n=12), and I/R+adenosine A2a receptor antagonist ZM241385 group (I/R+ZM group, n=12).Myocardial I/R injury model was established by ligation of left anterior descending coronary artery (LAD), which was followed by reperfusion. In I/R+CGS group, CGS21680 was injected intravenously before reperfusion and maintained for 60 min. In CGS+ZM group, ZM241385 was intravenously administered 5 min before reperfusion. For each group, heart rate (HR) and mean arterial pressure (MAP) were recorded before modeling, at 5 min post ischemia, and 10 min, 45 min and 120 min after reperfusion, respectively. HR and systolic blood pressure product (RPP) was then calculated. Blood samples were collected after reperfusion, and serum levels of cardiac troponin I (cTnI) and fibroblast growth factor 21 (FGF21) were determined by enzyme-linked immunosorbent assay (ELISA). After reperfusion, LAD was ligated again, and percentage ofinfarct size (IS) was detected by TTC staining. Finally, all rats were sacrificed and the expression levels of TNF-α, IL-1β and KLF5 in myocardial tissue were determined by western blot. Results: HR, MAP and RPP did not significantly differ before modeling among 4 groups and at all time pointsin Sham group, but these measurements were decreased after 5 min of ischemiain I/R group (P<0.05). Compared with I/R group, HR, MAP, and RPP were reduced after 10 min and 45 min of reperfusion in I/R+CGS group (P<0.05), but were increased in I/R+ZM group (P<0.05). Compared with Sham group, IS was significantly increased in I/R group (P<0.05). IS was reduced in I/R+CGS group (P<0.05), but increased in I/R+ZM group (P<0.05). In parallel, compared with Sham group, serum cTnI was increased and FGF21 was decreased in I/R group (all P<0.05). Serum cTnI was decreased and FGF21 was increased in I/R+CGS group (P<0.05), however, serum cTnI was increased and FGF21 was decreased in I/R+ZM group (P<0.05). Similarly, compared with Sham group, expressions of TNF-α, IL-1β and KLF5 were increased in I/R group. The expressions of TNF-α, IL-1β and KLF5 were decreased in I/R+CGS group (P<0.05), but were increased in I/R+ZM group (P<0.05). Conclusion: Activation of adenosine A2a receptor could inhibit KLF5 expression in ischemic cardiomyocytes, reduce infarct size anddegree of hypoxia, and promote cardiac repair, exerting a protective effect aftermyocardial I/R injury in rats.

参考文献/References

[1]Shi X, Tao G, Ji L, et al. Sappanone A alleviates hypoxia/reoxygenation-induced cardiomyocytes injury through inhibition of mitochondrial apoptosis and activation of PI3K-Akt-Gsk-3β pathway[J]. Biosci Rep, 2020, 40(2):BSR20192442.
[2] 王正刚, 柯剑娟, 王焱林, 等. 激活腺苷A2A受体对糖尿病大鼠心肌缺血再灌注损伤的影响:与自噬的关系[J]. 中华麻醉学杂志, 2019, 39(4):418-421.
[3]Jia J, Zhang HB, Shi Q, et al. KLF5 downregulation desensitizes castration-resistant prostate cancer cells to docetaxel by increasing BECN1 expression and inducing cell autophagy[J]. Theranostics, 2019, 9(19):5464-5477.
[4]Bell KN, Shroyer NF. Krüpple-like factor 5 is required for proper maintenance of adult intestinal crypt cellular proliferation[J]. Dig Dis Sci, 2015, 60(1):86-100.
[5]Luo Y, Chen C. The roles and regulation of the KLF5 transcription factor in cancers[J]. Cancer Sci, 2021, 112(6):2097-2117.
[6]Gao J, Chen G, He H, et al. Therapeutic effects of breviscapine in cardiovascular diseases: a review[J]. Front Pharmacol, 2017, 8:289.
[7]Wen ZJ, Xin H, Wang YC, et al. Emerging roles of circRNAs in the pathological process of myocardial infarction[J]. Mol Ther Nucleic Acids, 2021, 26:828-848.
[8]Huang Y. The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases[J]. J Cell Mol Med,2018, 22(12):5768-5775.
[9]Oozawa S, Mori S, Kanke T, et al. Effects of HMGB1 on ischemia-reperfusion injury in the rat heart[J]. Circ J, 2008, 72(7):1178-1184.
[10] Kloner RA, Dow J, Bhandari A. Postconditioning markedly attenuates ventricular arrhythmias after ischemia-reperfusion[J]. J Cardiovasc Pharmacol Ther, 2006, 11(1):55-63.
[11] Lim SY, Davidson SM, Hausenloy DJ, et al. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore[J]. Cardiovasc Res, 2007, 75(3):530-535.
[12] Peoples GE, McLennan PL, Howe PR, et al. Fish oil reduces heart rate and oxygen consumption during exercise[J]. J Cardiovasc Pharmacol, 2008, 52(6):540-547.
[13] Gong L, Wang Z, Wang Z, et al. Sestrin2 as a potential target for regulating metabolic-related diseases[J]. Front Endocrinol (Lausanne), 2021, 12:751020.
[14] Fassett J, Xu X, Kwak D, et al. Adenosine kinase attenuates cardiomyocyte microtubule stabilization and protects against pressure overload-induced hypertrophy and LV dysfunction[J]. J Mol Cell Cardiol, 2019, 130:49-58.
[15] 周慧敏, Mohamed BM, 夏韵, 等. 激活腺苷A2B受体对大鼠心肌缺血再灌注时自噬的影响:PI3K/Akt信号通路在其中的作用[J]. 中华麻醉学杂志, 2021, 41(5):612-615.
[16] Pol CJ, Pollak NM, Jurczak MJ, et al. Cardiac myocyte KLF5 regulates body weight via alteration of cardiac FGF21[J]. Biochim Biophys Acta Mol Basis Dis, 2019, 1865(9):2125-2137.
[17] Li Y, Lin M, Lin P, et al. Maternal high-fat diet alters the characteristics of astrocytes and worsens the outcome of stroke in rat offspring, which improves after FGF21 administration[J]. Front Cell Dev Biol, 2022, 9:731698.
[18] Dong X, Zhou M, Li Y, et al. Cardiovascular protective effects of plant polysaccharides: a review[J]. Front Pharmacol, 2021, 12:783641.
[19] Major JL, Bagchi RA, Pires da Silva J. Application of microRNA database mining in biomarker discovery and identification of therapeutic targets for complex disease[J]. Methods Protoc, 2020, 4(1):5.
[20] Jiang W, Song J, Zhang S, et al. CTRP13 protects H9c2 cells sgainst hypoxia/reoxygenation (H/R)-induced injury via regulating the AMPK/Nrf2/ARE signaling pathway[J]. Cell Transplant, 2021, 30:9636897211033275.
[21] Katarzyna R. Adult stem cell therapy for cardiac repair in patients after acute myocardial infarction leading to ischemic heart failure: an overview of evidence from the recent clinical trials[J]. Curr Cardiol Rev, 2017, 13(3):223-231.
[22] Wang YH, Li SA, Huang CH, et al. Sirt1 activation by post-ischemic treatment with lumbrokinase protects against myocardial ischemia-reperfusion injury[J]. Front Pharmacol, 2018, 9:636.
[23] Chen HL, Chong IW, Lee YC, et al. Krüppel-like factor 5 mediates proinflammatory cytokine expression in lipopolysaccharide-induced acute lung injury through upregulation of nuclear factor-κB phosphorylation in vitro and in vivo[J]. Mediators Inflamm, 2014, 2014:281984.
[24] Kikuchi K, Tancharoen S, Takeshige N, et al. The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease[J]. Int J Mol Sci, 2013, 14(7):13909-13930.
[25] IFCC Committee on standardization of markers of cardiac damage: premises and project presentation[J]. EJIFCC, 1999, 11(2):45-48.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81471858)
更新日期/Last Update: 2023-05-30